Product Information
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $3941.7995 per ML under NDC 00078063941. Its NADAC has been published 475 times since Jul 19, 2017.
Strength
150 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078063941
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has been published 475 times since Jul 19, 2017, and over the history we have for it it has risen 87.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3941.7995 per ML |
|---|---|
| All-time high | $3976.8992 (Jun 10, 2026) |
| All-time low | $2106.4112 (Jul 19, 2017) |
| 52-week high | $3976.8992 |
| 52-week low | $3691.2023 |
| Median price | $3045.4215 |
| Average price | $3019.5177 |
| Largest weekly change | +9.9% (Jan 23, 2019) |
| Weeks tracked | 475 |
| Tracking since | Jul 19, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), manufactured by Novartis Pharmaceuticals Corporation, is $3941.7995 per ML (NDC 00078063941), effective Aug 19, 2026.
How has the price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) changed over time?
Over the history we have for it, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has risen 87.1%. It has been tracked across 475 weekly CMS publications since Jul 19, 2017.
What are the highest and lowest recorded NADAC prices for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
Since Jul 19, 2017, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has ranged from a low of $2106.4112 (Jul 19, 2017) to a high of $3976.8992 (Jun 10, 2026), with a median of $3045.4215 per ML.
Are there cheaper alternatives to COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, is $3924.3531 per ML — about 0% below COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN).
Who manufactures COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) (NDC 00078063941) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.